Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

LIXT

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

CIK 0001335105 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$7.21
↓ 0.46 (-6.00%)
as of Jul 2, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$89.28M
P/E Ratio
-12.14
EPS
Not covered
Dividend Yield
Not covered
52W Position
84%
Beta
0.69

Valuation multiples

Fwd P/E
Not covered
PEG
0.00
P/B
9.73
P/S
Not covered
EV/Revenue
Not covered
ROE
-80.2%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

247 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 84%
$1.28$8.38

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$6.08M
Total Assets
$12.73M
Free Cash Flow
–

Recent news